Literature DB >> 16076015

Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.

S Vivekanandhan1, C C Soundararajan, M Tripathi, M C Maheshwari.   

Abstract

Multiple sclerosis (MS) is one of the most common causes of neurological disability in young and middle-aged adults and is thought to be mediated by autoreactive T cells. Activities of adenosine deaminase (ADA) and 5'(nucleotidase (5'NT), which are involved in the differentiation and maturation of the lymphoid system, were measured in peripheral blood T cells from 21 MS patients and in 23 age and sex matched healthy controls to determine whether an association existed between these enzyme abnormalities and cellular immune functions. ADA and 5'NT activities were found significantly decreased in MS patients (P < .001 and P < .01 respectively) when compared with controls. Low levels of ADA and 5'NT activities were found irrespective of whether patients had relapsing-remitting or chronic progressive MS. These findings suggest that low levels of these enzyme activities in T cells may be related to the persistent abnormalities in T cell function in the clinical course of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076015     DOI: 10.1007/s11064-005-2680-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.

Authors:  S G Apasov; M R Blackburn; R E Kellems; P T Smith; M V Sitkovsky
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

3.  Lymphocyte function and the role of regulator cells in multiple sclerosis.

Authors:  J P Antel; D P Richman; M E Medof; B G Arnason
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

4.  Purification of human T and B lymphocytes.

Authors:  M F Greaves; G Brown
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

5.  Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.

Authors:  V Nikolajeva; D Eze; Z Petrina; I Muiznieks
Journal:  J Autoimmun       Date:  2000-03       Impact factor: 7.094

6.  The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase.

Authors:  S G Apasov; M V Sitkovsky
Journal:  Int Immunol       Date:  1999-02       Impact factor: 4.823

7.  Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.

Authors:  J F Salazar-Gonzalez; D J Moody; J V Giorgi; O Martinez-Maza; R T Mitsuyasu; J L Fahey
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

Review 8.  Multiple sclerosis: Indian experience in the last thirty years.

Authors:  S Jain; M C Maheshwari
Journal:  Neuroepidemiology       Date:  1985       Impact factor: 3.282

9.  Suppressor cell activity in multiple sclerosis.

Authors:  W C Wallen; S A Houff; M Iivanainen; V P Calabrese; G H DeVries
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  3 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.

Authors:  Marek Cieślak; Filip Kukulski; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

3.  Adenosine and lymphocyte regulation.

Authors:  Stefania Gessi; Katia Varani; Stefania Merighi; Eleonora Fogli; Valeria Sacchetto; Annalisa Benini; Edward Leung; Stephen Mac-Lennan; Pier Andrea Borea
Journal:  Purinergic Signal       Date:  2007-01-16       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.